Viewing StudyNCT05438368



Ignite Creation Date: 2024-05-06 @ 5:47 PM
Last Modification Date: 2024-10-26 @ 2:36 PM
Study NCT ID: NCT05438368
Status: RECRUITING
Last Update Posted: 2022-06-30
First Post: 2022-06-21

Brief Title: GD2CD70 Bi-specific CAR-T Cell Therapy
Sponsor: Shenzhen Geno-Immune Medical Institute
Organization: Shenzhen Geno-Immune Medical Institute

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-06-30
Start Date Type: ESTIMATED
Primary Completion Date: 2025-12-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-06-30
Completion Date Type: ESTIMATED
First Submit Date: 2022-06-21
First Submit QC Date: June 25 2022
Study First Post Date: 2022-06-30
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-06-25
Last Update Post Date: 2022-06-30
Last Update Post Date Type: ACTUAL